A detailed history of Bokf, Na transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bokf, Na holds 15,400 shares of HRMY stock, worth $526,372. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,400
Previous 14,710 4.69%
Holding current value
$526,372
Previous $587,000 9.88%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$31.86 - $41.49 $21,983 - $28,628
690 Added 4.69%
15,400 $529,000
Q3 2024

Nov 14, 2024

BUY
$30.0 - $39.95 $441,300 - $587,664
14,710 New
14,710 $587,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.